Determinants of Life Satisfaction in Inflammatory Bowel Disease

Janke, Karl-Heinz; Klump, Bodo; Gregor, Michael; Meisner, Christoph; Haeuser, Winfried

doi:10.1097/01.mib.0000160809.38611.f7

Cited by 127 publications

(97 citation statements)

References 30 publications

(71 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Extensive research has highlighted the major impact that IBD holds on patients' quality of life (QoL) and psychosocial functioning [e.g., [1][2][3]. IBD often leads to feelings of shame, embarrassment and isolation, concerns regarding the risk of relapsing or developing cancer, difficulty in maintaining daily routines due to severe symptomatology that may arise abruptly, and struggles with body dissatisfaction and sexuality [4][5][6][7][8].…”

Section: Inflammatory Bowel Disease and Psychological Distressmentioning

confidence: 99%

An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood

Trindade

Ferreira

Moura‐Ramos

et al. 2017

Int J Colorectal Dis

View full text Add to dashboard Cite

Depressive symptomatology in IBD patients is known to predict disease activity, which in turn can increase depressive symptoms in a perpetuating a cycle between depression and IBD symptomatology. The mechanisms that contribute to the relationship between disease activity and depressive symptoms are not clearly investigated yet. Since emotion regulation has been considered particularly relevant to define the impact of adverse experiences on different outcomes, the current study aimed to examine the longitudinal influence of two maladaptive emotion regulation processes, cognitive fusion and brooding, on the association between disease activity and depressed mood. This study was conducted over an 18-month period, using a sample of 116 IBD patients that completed self-report validated measures in three different waves.Correlation analyses and cross-lagged panel models were performed.The main result from this study discovered that the experience of IBD symptomatology at baseline, although positively linked to the manifestation of depressed mood 18 months later (r = 0.25; p < 0.01), does not directly predict depressive symptoms.This relationship is rather indirect, as it is explained by the engagement in cognitive fusion (p = 0.028) and brooding (p = 0.017). These maladaptive emotion regulation processes, that were revealed to be consistent over time, link IBD symptoms with subsequent depressed mood.These findings indicate that clinicians should be aware of the emotion regulation processes patients tend to use to handle difficult experiences. The inclusion of 4 psychological assessments and interventions in the healthcare of IBD patients should be seriously considered. Further implications are discussed.

show abstract

Section: Inflammatory Bowel Disease and Psychological Distressmentioning

confidence: 99%

An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood

Trindade

Ferreira

Moura‐Ramos

et al. 2017

Int J Colorectal Dis

View full text Add to dashboard Cite

show abstract

“…54,55 There is evidence to suggest depression in particular can have a detrimental impact on disease course, 28,28-59 IBD treatment outcomes, 58 and overall quality of life for IBD patients. 75,76 The relationship between depression and disease course may be influenced in part by the effect of the disorder on treatment adherence, as there is significantly poorer adherence to treatment regimens by those with a comorbid psychiatric disorder. 77,78 Finally, 17% of those with a major depressive disorder and IBD had considered suicide in the previous 12 months, 34 raising a concern about the mortality risks associated with comorbid depression.…”

Section: Managing Comorbid Anxiety and Depression In Ibdmentioning

confidence: 99%

Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management

Graff

Walker

Bernstein

2009

Inflammatory Bowel Diseases

511

358

View full text Add to dashboard Cite

“…[21][22][23] Despite the proven efficacy and safety of rectally administered 5-ASA, patients have demonstrated lower compliance rates with topical compared with oral therapy. [22] Noncompliance results in an increased risk for disease relapse, [21,24] a diminished quality of life, [7,25,26] and a possible increase in the risk for colorectal cancer. [27] Therefore, successful management of patients with ulcerative colitis requires treatment strategies that encourage and confirm compliance with the prescribed therapeutic plan.…”

Section: Induction Of Remission In Ulcerative Colitismentioning

confidence: 99%

Discussion About Treatment of Ulcerative Colitis.

alfattany¹,

sharif²,

SalemMabkhot³

et al. 2017

IJAR

View full text Add to dashboard Cite

Determinants of Life Satisfaction in Inflammatory Bowel Disease

Abstract: To improve GLS and HRLS in inflammatory bowel disease, both the treatment of bowel disease and medical and psychiatric comorbidity are necessary. Strengthening of social support is an additional way to promote GLS.

Cited by 127 publications

References 30 publications

An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood

An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood

Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management

Discussion About Treatment of Ulcerative Colitis.

Contact Info

Product

Resources

About